Health effects of therapeutic use of 131I in hyperthyroidism

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 4, 2000, Pages 333-339

  Pauwels, E K J ^a   Smit, J W A ^a   Slats, A ^a   Bourguignon, M ^a   Overbeek, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Graves' disease; Hyperthyroidism; Iodine radioisotopes, adverse effects; Iodine radioisotopes, therapeutic use

Indexed keywords

IODINE 131; STEROID; THYROID HORMONE;

BENIGN TUMOR; BLADDER CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; EUTHYROIDISM; EYE DISEASE; GENETIC DISORDER; GRAVES DISEASE; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IMMUNOLOGY; INCIDENCE; KIDNEY CANCER; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; NODULAR GOITER; RADIATION DOSE; REVIEW; RISK BENEFIT ANALYSIS; SALIVARY GLAND DISEASE; STOMACH CANCER; THYROID CANCER; THYROID DISEASE; TOXIC GOITER;

HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIATION INJURIES;

EID: 0034478098     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Treatment of Graves' hyperthyroidism with radioiodine: Results of a prospective randomized study
2. Radioiodine therapy of the thyroid
3. The physics and chemistry of radiation absorption
4. Molecular radiation biology
5. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism
6. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease
7. Clinical outcome and costs of care in radioiodine treatment of hyperthyroidism
8. Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years?
9. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease
10. Ablative radioiodine therapy for hyperthyroidism: Long term follow up study
11. Hypothyroidism following radioiodine treatment of thyrotoxicosis
12. Transient hypothyroidism
13. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis
14. Transient hypothyroidism following radioiodine therapy for thyrotoxicosis
15. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism and prognosis
16. Radioiodine treatment of multinodular non-toxic goitre
17. Iodine-131 therapy of hyperthyroidism in pediatric patients
18. 131I treatment in patients with nontoxic goiter
19. Radioiodine for nontoxic multinodular goiter
20. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group
21. Large doses of radioiodine in Graves' disease: Effect on ophthalmopathy and long-acting thyroid stimulator
22. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction
23. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy
24. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management
25. Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodine
26. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology
27. Radioiodine secretion in tears
28. Hypoparathyroidism after iodine-131 treatment of thyrotoxicosis
29. Cancer incidence following treatment of hyperthyroidism
30. Induction of hyperparathyroidism by radioactive iodine
31. Effects of the length of radioiodine treatment of hyperthyroidism on the distribution of blood levels of calcium and phosphorus as a function of sex and age
32. Hyperparathyroidism after treatment with radioactive iodine: Not only a coincidence?
33. The use of radioactive iodine in thyroid carcinoma
34. Two cases of lymphoma of the parotid gland following ablative radioiodine therapy for thyroid carcinoma
35. A case report of mucoepidermoid carcinoma of the parotid gland developing after radioiodine therapy for thyroid carcinoma
36. Differential kinetics of parotid and submandibular gland function as demonstrated by scintigraphic means and its possible implications
37. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine
38. Place of radioactive iodine in treatment of thyrotoxicosis
39. Radio-iodine treatment of hyperthyroidism - A more liberal policy?
40. 131I exposure: Study in hyperthyroidism patients
41. 131I treatment in hyperthyroidism patients
42. The role of iodine in carcinogenesis
43. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987
44. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies
45. Chernobyl-related thyroid cancer in children of Belarus: A case-control study
46. Mortality in patients treated for hyperthyroidism with iodine-131
47. Late consequences of radioiodine for diagnosis and therapy in Sweden
48. Cancer mortality after iodine-131 therapy for hyperthyroidism
49. Cancer risk after iodine-131 therapy for hyperthyroidism
50. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group
51. Mortality after the treatment of hyperthyroidism with radioactive iodine
52. The current mortality rates of radiologists and other physician specialists: Specific causes of death
53. Expectation of life and mortality from cancer among British radiologists
54. Radiation cancer in Japanese radiological workers
55. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86)
56. Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis
57. Leukemia following radiotherapy for uterine bleeding
58. Mortality after radiotherapy for ringworm of the scalp
59. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study
60. 131-I treatment of thyroid carcinoma
61. The long-term hazards of the treatment of thyroid cancer with radioiodine
62. Cancer risks in thyroid cancer patients
63. Leukaemia incidence after iodine-131 exposure
64. Radioactive iodine therapy and breast cancer: A follow-up study of hyperthyroid women